Clinical Trial Applications - Suspended: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Suspended | |
|---|---|---|---|---|---|
1. |
ECCT/20/05/03 | A5381 Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or with Rifampicin-Containing TB Treatment |
Principal Investigator(s) 1. Victor Mudhune Site(s) in Kenya Kisumu Clinical Research Center |
Not recorded |
View |